Disc Medicine, Inc. (NASDAQ: IRON) is a Healthcare company (Biotechnology) with a market capitalization of $2.9B. The Maz Rating grades it against the other companies in its sector.
Disc Medicine, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $76.57, Disc Medicine, Inc. trades at 4.9x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -36.3%, return on invested capital of -39.9% and a free cash flow yield of -6.5%. On the balance sheet: a debt-to-equity ratio of 0.10 and a current ratio of 20.30. Over the past 52 weeks the share price ranged from $40.00 to $99.50, with a beta of 2.01.
Disc Medicine, Inc. does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 1 Strong Buy and 10 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.